Clinical Trial for Myelofibrosis

Imago BioSciences is working to bring new medicines to patients who have myeloproliferative neoplasms. In keeping with this goal, Imago has initiated a Phase 2 clinical trial to evaluate the safety and efficacy of IMG-7289 (bomedemstat) in patients with myelofibrosis.